Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Results Update

RPG Life Sciences Results Update

RPG Life Sciences reported a 23.6% Y-o-Y revenue increase to ₹176.9 Crore for Q4 FY26, with an EBITDA margin of 25.6%. Full-year FY26 revenue grew 8.3% to ₹707.5 Crore. The Board recommended a 300% dividend (₹24 per share). Growth was driven by robust performance in Domestic Formulations and a strong recovery in the API division.

Source

BSE filing, NSE: RPGLIFE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

RPG Life Sciences Ltd: key numbers

Share price
₹2,844.00
Market cap
₹4,704 Cr
Revenue (annual)
₹707.5 Cr
Net profit (annual)
₹115.2 Cr
P/E (TTM)
39.3×Sector 46.1×
Promoter holding
72.95%+0.00% QoQ
FII holding
0.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from RPG Life Sciences Ltd

All →

Other results update announcements

All →